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Preliminary observations of genetic susceptibility of elk (Cervus elaphus nelsoni)
to chronic wasting disease by experimental oral inoculation
Amir N. Hamir,1 Thomas Gidlewski, Terry R. Spraker, Janice M. Miller,
Lynn Creekmore, Michelle Crocheck; Thomas Cline, Katherine I. O’Rourke
Abstract. To compare the genetic susceptibility of elk (Cervus elaphus nelsoni) with various alleles of the
PRNP gene, which encodes the normal cellular prion protein, to chronic wasting disease (CWD), eight 8-month-
old elk calves of 3 genotypes (2 132MM, 2 132LM, and 4 132LL) were orally dosed with CWD-infected brain
material from elk. During postinoculation (PI) month 23, both 132MM elk had lost appetite, developed clinical
signs of weight loss and central nervous system (CNS) dysfunction, and were euthanized. Two other elk (both
132LM) developed similar clinical signs of disease and were euthanized during PI month 40. All 4 affected
elk had microscopic lesions of spongiform encephalopathy (SE), and PrPres, the disease-associated form of the
prion protein, was detected in their CNS and lymphoid tissues by use of immunohistochemical (IHC) and
Western blot (WB) techniques. These findings indicate that elk with MM and LM at codon 132 are susceptible
to orally inoculated CWD. All 4 LL elk are alive at PI year 4 and are clinically normal, which suggests that
132LL elk may have reduced susceptibility to oral infection with CWD-infected material or may have prolonged
incubation time.
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Chronic wasting disease (CWD) is a fatal spongi-
form encephalopathy, or prion disease, of cervids in
North America. The natural disease has been docu-
mented in mule deer (Odocoileus hemionus hemionus),
black-tailed deer (O. hemionus columbianus), white-
tailed deer (O. virginianus), and Rocky Mountain elk
(Cervus elaphus nelsoni).12,16,17
Elk that are homozygous for the allele encoding me-
thionine (M) at codon 132 of PRNP (the gene encod-
ing the normal cellular prion protein) are over-repre-
sented in free-ranging and farm-raised CWD-affected
elk, compared with unaffected control groups.7,11
Chronic wasting disease has been confirmed in elk het-
erozygous for 132M and the alternative allele encod-
ing leucine (L) at codon 132. However, to the authors’
knowledge, only 1 confirmed case of CWD in an elk
homozygous for 132L has been reported.11 The pur-
pose of the study reported here was to determine the
influence of codon 132 on susceptibility and incuba-
tion time in elk that had been experimentally exposed
by oral inoculation of CWD-infected brain.
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Eight 8-month-old elk calves were obtained from a
game farm on which captive elk were raised. The farm
consisted of 3 distinct premises, and elk were moved
among these for breeding, meat production, pilose ant-
ler production, and educational display. A case of
CWD was confirmed on December 18, 1997, although
it is probable that there were earlier undiagnosed cases.
An additional 78 cases were diagnosed, the latest on
March 5, 2001, when the last of the elk, white-tailed
deer, and mule deer were depopulated from the 3 pre-
mises. None of the CWD-positive elk were homozy-
gous for 132L. After the report of predisposition to
disease in elk homozygous for 132M, the Elk Research
Council of the North American Elk Breeders’ Asso-
ciation and US Department of Agriculture (USDA),
Agricultural Research Service (ARS) assisted the pro-
ducer with a selective breeding program to develop a
population of 132LL elk using 132LM and 132LL
cows and 132LL bulls. Four 132LL calves from the
summer 2000 birth group were moved to a quarantine
facility at the National Veterinary Services Laborato-
ries (NVSL) in Ames, IA in February and March of
2001. Two 132MM and two 132LM calves were ob-
tained from a separate breeding group kept in 1 of the
other 2 premises. Genotyping was performed as de-
scribed7 on buffy coat cells collected from live animals
and on brain specimens collected at necropsy and fro-
zen. Because of the high CWD prevalence at this fa-
cility, infection with CWD before movement to the
quarantine facility cannot be ruled out.
Material for inoculation was prepared from the
pooled frozen brain specimens of 2 CWD-affected
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Rocky Mountain elk (one 132MM and one 132LM)
from the infected herd. Both elk were adult cows that
were manifesting clinical signs suggestive of CWD at
the time of necropsy. Approximately 150 g of brain
was mixed with 15 ml of saline and placed in sterile
stomacher bagsa and blended in ‘‘The Stomacher.’’b At
approximately 8 months of age, each elk was given 3
ml of the mixture per os daily for 5 consecutive days.
The material was aspirated into a 20-ml syringe, then
was instilled in the posterior portion of the oral cavity.
Material was not lost during this procedure. The pool
was positive for PrPres, the disease-associated form of
the prion protein, by use of immunohistochemical
(IHC) and Western blot (WB) analyses.
Calves were housed in a biosafety level-2 isolation
barn at the NVSL, Ames, IA. Husbandry of these an-
imals has been described.4 Personnel wore protective
clothing while in the isolation facility and showered
before leaving the facility. Animals were euthanized
when clinical signs suggestive of CWD (weight loss,
ataxia) were observed.
Euthanasia was done by administering an overdose
of pentobarbital, and a complete necropsy was con-
ducted on each of the carcasses. The brain was cut
longitudinally; one half was fixed in formalin for not
less than 3 weeks, and the other half was frozen at
2208C. The formalin-fixed brain was cut into 2- to 4-
mm-thick coronal sections. Sections from various an-
atomic sites (10 to 15 sections/animal) of cerebrum,
cerebellum, and brainstem (including the medulla ob-
longata at the level of the obex) were processed in
routine manner for histologic examination, embedded
in paraffin wax, and sectioned at 5-m thickness. The
sections were stained with hematoxylin and eosin
(HE), and by an IHC method for detection of PrPres as
described.6,11 Monoclonal antibody F99/97.6.15,c was
used for the detection of PrPres. This antibody recog-
nizes cervid, ovine, and bovine transmissible spongi-
form encephalopathy (TSE)-positive brain after anti-
gen retrieval and treatment with formic acid.11 In this
study, CNS tissue, palatine tonsil, retropharyngeal
lymph node, and gut-associated lymphoid tissue were
examined.
For immunodetection of PrPres, a previously de-
scribed method13 was used on frozen brain (caudal por-
tion of the medulla). If no signal was detected using
detergent extracts of the brain, the samples were en-
riched for PrPres using phosphotungstic acid precipi-
tation.15 Samples were considered test positive when
the 3 isoforms of the pathologic form of the prion
protein, PrPres were detected on the immunoblot after
proteinase K enzyme treatment. A positive-control
sample was prepared from the brain of a free-ranging
elk (genotype 132MM) from Colorado with naturally
acquired clinical disease.
By postinoculation (PI) month 23, both 132MM an-
imals had lost their appetite, developed clinical signs
of weight loss and CNS dysfunction, and were eutha-
nized. Two other elk (both LM) developed similar clin-
ical signs of disease and were euthanized during PI
month 40. All 4 clinically ill animals had microscopic
lesions of spongiform encephalopathy (SE) character-
ized by intraneuronal vacuolation, microcavitation of
gray matter, neuronal degeneration, and mild astrocy-
tosis, as described in deer and elk.13,16,17 The micro-
cavitation of gray matter was more prevalent than the
intraneuronal vacuolation and neuronal degeneration
(Fig. 1). The intensity of the SE within the vagus and
surrounding nuclei was considered severe in all 4 elk.11
There was no detectable difference in distribution or
severity of lesions between the 132MM elk and the
132LM elk.
Abnormal prion protein was detected throughout the
brain and selected lymphoid tissues of all 4 elk by use
of IHC as described.8,11,13 The appearance of PrPres in
the brain was a coarse red granular material, which
was scattered throughout the neuropil, but was espe-
cially evident surrounding neurons. Intraneuronal
staining was rare (Fig. 2). In all 4 elk, abnormal prion
protein was abundant within lymphoid follicles of the
palatine tonsil, retropharyngeal lymph node, and gut-
associated lymphoid tissue (Peyer’s patches).11,13 There
was no difference in staining intensity or distribution
between the 132MM and 132LM elk.
The PrPres was also detected by WB analysis in brain
material from the 4 IHC-positive animals and the oral
inoculum. Starting wet weight required for a detectable
signal was 15 mg for the homogenized inoculum and
0.1 to 1.7 mg for caudal medulla samples. A distinct
profile of the 3 isoforms of PrPres (di-glycosylated,
mono-glycosylated, and unglycosylated polypeptides)
is shown in Fig. 3). The 5 samples had migration pat-
terns similar to that of a reference sample prepared
from the brain of a wild-caught elk with naturally ac-
quired CWD.
Like all other TSEs, CWD is characterized by a long
incubation period. Naturally affected elk manifest
changes in behavior, excess salivation, and terminal
emaciation.16 In the study reported here, similar clini-
cal signs of disease were observed in 4 elk with either
132MM or 132LM genotype. The average PI incuba-
tion period for the 132MM and 132LM elk was 22.8
and 39.2 months, respectively. Characteristic morpho-
logic changes of SE in CNS tissues were observed in
all affected elk, and were not appreciably different in
the homozygous and heterozygous groups. The PrPres
was observed in the affected elk and was documented
by use of IHC analysis of neural and lymphoid tissues
and was confirmed by use of WB analysis of frozen
brain.
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Figure 1. Brain; medulla oblongata, animal No. 1. Notice presence of severe diffuse spongiform encephalopathy characterized by clear
vacuolation of neuropil and occasional presence of clear vacuole within neuronal cytoplasm (arrow). HE.
At PI year 4, the four 132LL elk are clinically nor-
mal. Because these elk were inoculated, it is certain
that they will have a longer incubation period than that
of the 132MM or 132LM elk. Therefore, on the basis
of these preliminary observations, elk with 132MM
genotype appear to have the shortest incubation period
(during PI year 2). Elk with 132LM genotypes appear
to be equally susceptible to the disease, but have a
longer incubation period (up to PI year 3.5). Similar
results were obtained when the sheep scrapie agent
was inoculated into elk; the incubation period for the
132MM and 132LM elk was 3 and 4 years, respec-
tively.4 The incubation period for CWD in 132LL elk
may be long, and the 4 surviving animals will be
maintained for an additional period of 2 years (total
of 6 years after inoculation). At that time, the elk will
be euthanized and examined for CWD.
This study involved a small number of animals that
were selected from an infected facility and exposed to
CWD through experimental challenge. To further an-
swer the issue of survival of 132LL elk exposed to
CWD, larger numbers of animals, including animals
sourced from CWD-free facilities, will be needed; in
addition, natural cases of CWD provided by state reg-
ulatory agencies will be genotyped. To determine
whether 132LL elk have the same long incubation pe-
riod or low susceptibility phenotype when exposed to
CWD from other species, a subsequent experiment
may be necessary, in which 132LL elk would be in-
oculated intracerebrally with CWD-infected material
from mule deer and white-tailed deer.
The association between polymorphisms in the open
reading frame of the PRNP gene and susceptibility/
incubation time is well documented in natural sheep
scrapie, murine experimental models, and some forms
of human TSE.1,3 In addition, the association between
TSE susceptibility and changes in the noncoding re-
gion of the PRNP gene or in putative accessory mol-
ecules have been suggested in several ovine, bovine,
and murine studies.2,9,10,14 The polymorphism at codon
132 was the only coding change observed in the open
reading frame of the PRNP gene in the elk of this
study. However, the four 132LL elk are progeny of
long-term survivors in the heavily infected source
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Figure 2. Brain; medulla oblongata, animal No. 1. Notice extensive presence of PrPres staining (red) in the neuropil, predominantly within
the neuropil and around neurons and blood vessels. Stained for PrPres by IHC.
Figure 3. Western blot showing distinct profile of PrPres in the 4 test-positive elk. Lanes: 1, positive control (wild caught elk from
Colorado); 2, elk No. 2; 3, inoculum; 4, elk No. 4; 5, elk No. 1; and 6, elk No. 3. Samples were prepared as homogenates without (lanes
1, 4, 5 and 6) or after enrichment by PTA precipitation (lanes 2 and 3). Molecular weight markers (kDa) are shown on the left.
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herd, and the prolonged incubation period or protec-
tion from disease may be mediated by additional or
alternative genetic factors. Polymorphisms within and
outside of the PRNP gene complex are under investi-
gation.
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